HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing (Q34112620)

31 July 2017

title

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing (English)

1 reference

31 July 2017

Margaret Littlejohn

2

0 references

Peter Revill

Peter A Revill

19

0 references

Sharon R. Lewin

Sharon R Lewin

18

0 references

Kiat Ruxrungtham

14

Kiat Ruxrungtham

1 reference

31 July 2017

17

Chloe L Thio

1 reference

31 July 2017

11

Eric Seaberg

1 reference

31 July 2017

15

Gregory J Dore

1 reference

31 July 2017

Anchalee Avihingsanon

10

Anchalee Avihingsanon

1 reference

31 July 2017

Jennifer Audsley

1

1 reference

31 July 2017

Lilly Yuen

3

1 reference

31 July 2017

Joe Sasadeusz

4

1 reference

31 July 2017

Anna Ayres

5

1 reference

31 July 2017

Christopher Desmond

6

1 reference

31 July 2017

Tim Spelman

7

1 reference

31 July 2017

George Lau

8

1 reference

31 July 2017

Gail V Matthews

9

1 reference

31 July 2017

Frances Philp

12

1 reference

31 July 2017

Melissa Saulynas

13

1 reference

31 July 2017

Stephen A Locarnini

16

1 reference

31 July 2017

language of work or name

English

0 references

publication date

23 July 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

405

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

539-547

1 reference

Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children.

31 July 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935930

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

5 July 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Genotype C of hepatitis B virus can be classified into at least two subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Not so different after all: a comparison of methods for detecting amino acid sites under selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Viral Quasi-Species Evolution During Hepatitis Be Antigen Seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Molecular evolution of hepatitis B virus over 25 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Datamonkey: rapid detection of selective pressure on individual sites of codon alignments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

HyPhy: hypothesis testing using phylogenies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Hepatitis B virus mutations in the pre-S genome before and after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

Mutational analysis of hepatitis B surface antigen particle assembly and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

7 January 2021

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

7 January 2021

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

7 January 2021

Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.038

7 January 2021

10.1016/J.VIROL.2010.06.038

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference